The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ilyicheva T.N.

Novosibirsk State University;
Vector State Research Center of Virology and Biotechnology

Netesov S.V.

Novosibirsk State University

Gureyev V.N.

Vector State Research Center of Virology and Biotechnology

COVID-19, influenza, and other acute respiratory viral infections: etiology, immunopathogenesis, diagnosis, and treatment. Part I. COVID-19 and influenza

Authors:

Ilyicheva T.N., Netesov S.V., Gureyev V.N.

More about the authors

Journal: Molecular Genetics, Microbiology and Virology. 2022;40(1): 3‑11

DOI: 10.17116/molgen2022400113

Read: 5683 times

Download PDF (RU)
Contact the author
Table of contents

COVID-19, INFLUENZA, AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS: ETIOLOGY, IMMUNOPATHOGENESIS, DIAGNOSIS, AND TREATMENT. PART I. COVID-19 AND INFLUENZA
COVID-19, INFLUENZA, AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS: ETIOLOGY, IMMUNOPATHOGENESIS, DIAGNOSIS, AND TREATMENT. PART I. COVID-19 AND INFLUENZA

To cite this article:

Ilyicheva TN, Netesov SV, Gureyev VN. COVID-19, influenza, and other acute respiratory viral infections: etiology, immunopathogenesis, diagnosis, and treatment. Part I. COVID-19 and influenza. Molecular Genetics, Microbiology and Virology. 2022;40(1):3‑11. (In Russ.)
https://doi.org/10.17116/molgen2022400113

Подписка 2026 Молекулярная генетика, микробиология и вирусология (Molecular Genetics, Microbiology and Virology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Sele­ctive anosmia for mono­molecular odorants in a cohort of young indi­viduals. Russian Rhinology. 2024;(4):262-268
The resu­lts of the examination of patients with chro­nic gene­ralized periodontitis after novel coro­navirus infe­ction. Russian Journal of Stomatology. 2024;(4):18-22
Waiting for Disease X: a plan for preparing Russian labo­ratory services for the next pandemic. Labo­ratory Service. 2024;(4):5-11
Deve­lopment and testing of the first dome­stic auto­matic cartridge-type POCT platform for the qualitative dete­rmination of SARS-CoV-2 RNA. Labo­ratory Service. 2024;(4):21-27
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59
Abstract:

The paper briefly reviews pathogens causing acute respiratory viral infections, ARVI, including influenza viruses, coronaviruses (in particular SARS-CoV-2), parainfluenza viruses, adenoviruses, pneumoviruses and specifically respiratory syncytial virus and metapneumoviruses, enteroviruses, rhinoviruses, and bocaviruses. The review presents modern data on the structure and replication of viruses, epidemiology and immunopathogenesis of diseases; diagnostics, preventive vaccination, and antiviral drugs prescribed in the course of ARVI treatment. Special attention is paid to the SARS-CoV-2 virus caused COVID-19 pandemic with analyses of similarities and differences between COVID-19 and other ARVI, first of all, influenza virus. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.

Keywords:

COVID-19
influenza
ARVI
respiratory viruses
SARS-CoV-2
viral replication
immunopathogenesis
ARVI prophylaxis

Authors:

Ilyicheva T.N.

Novosibirsk State University;
Vector State Research Center of Virology and Biotechnology

Netesov S.V.

Novosibirsk State University

Gureyev V.N.

Vector State Research Center of Virology and Biotechnology

Received:

29.04.2021

Accepted:

15.09.2021

Close metadata

References:

  1. Larina VN, Zaharova MI, Benevskaja VF, Golovko MG, Solov’ev SS. Acute respiratory viral infections and influenza: etiology, diagnosis and treatment algorithm. Russkij medicinskij zhurnal. Medicinskoe obozrenie. 2019;3(9-1):18-23. (In Russ.).
  2. Kurskaya O, Ryabichenko T, Leonova N, Shi W, Bi H, Sharshov K et al. Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013—2017). PLoS One. 2018;13(9):e0200117. https://doi.org/10.1371/journal.pone.0200117
  3. Lysholm F, Wetterbom A, Lindau C, Darban H, Bjerkner A, Fahlander K et al. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS One. 2012;7(2):e30875. https://doi.org/10.1371/journal.pone.0030875
  4. Weston S, Frieman MB. Respiratory viruses. In Encyclopedia of Microbiology, 4th edition. Elsevier. 2019;85-101. 
  5. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine. 2003;348(20):1967-1976. https://doi.org/10.1056/NEJMoa030747
  6. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier RAM. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. New England Journal of Medicine. 2012;367(19):1814-1820. https://doi.org/10.1056/NEJMoa1211721
  7. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020. 2020. Accessed April 20, 2021. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
  8. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2020;10.1038/s41579-020-00459-7.  https://doi.org/10.1038/s41579-020-00459-7
  9. Il’icheva TN. Two pandemics of the 21st century: COVID-19 and swine flu of 2009. Medicinskaja immunologija. 2020;22(6):1035-1044. (In Russ.). https://doi.org/10.15789/1563-0625-TPO-2048
  10. Shhelkanov MJu, Kolobuhina LV, Burgasova OA, Kruzhkova IS, Maleev VV. COVID-19: etiology, clinical picture, treatment. Infekcija i immunitet. 2020;10(3):421-445. (In Russ.).
  11. WHO Coronavirus Disease (COVID‐19) Dashboard. 2021. Accessed April 20, 2021. https://covid19.WHO.int/?gclid=Cj0KCQiAk53‐BRD0ARIsAJuNhps3swcAHiNCjnDRXQkz4UQO_qLXXLcFu6qbqUcRvfKLZ4EVgur3snIaAhT7EALw_wcB
  12. Wang WE, Tang JM, Wei FQ. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology. 2020;92(4):441-447.  https://doi.org/10.1002/jmv.25689
  13. Chen NS, Zhou M, Dong X, Qu JM, Gong FY, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.  https://doi.org/10.1016/s0140-6736(20)30211-7
  14. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. https://doi.org/10.1056/NEJMoa2002032
  15. Symproms of Coronavirus. 2021. Accessed April 20, 2021. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
  16. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-493.  https://doi.org/10.1126/science.abb3221
  17. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica. 2020;109(6):1088-1095. https://doi.org/10.1111/apa.15270
  18. Sharif-Askari NS, Sharif-Askari FS, Alabed M, Temsah MH, Al Heialy S, Hamid Q, Halwani R. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Molecular Therapy-Methods & Clinical Development. 2020;181-186.  https://doi.org/10.1016/j.omtm.2020.05.013
  19. Fajgenbaum DC, June CH. Cytokine storm. New England Journal of Medicine. 2020;383(23):2255-2273. https://doi.org/10.1056/NEJMra2026131
  20. Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, united states. Emerging Infectious Diseases. 2020;26(9):2005-2015. https://doi.org/10.3201/eid2609.202095
  21. Singh R, Kang A, Luo X, Jeyanathan M, Gillgrass A, Afkhami S, Xing Z. COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development. The FASEB Journal. 2021;35(3):e21409. https://doi.org/10.1096/fj.202002662R
  22. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine. 2020;382(13):1199-1207. https://doi.org/10.1056/NEJMoa2001316
  23. Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection. 2020. https://doi.org/10.1016/j.jmii.2020.03.022
  24. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-574.  https://doi.org/10.1016/S0140-6736(20)30251-8
  25. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020;24:91-98.  https://doi.org/10.1016/j.jare.2020.03.005
  26. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273.  https://doi.org/10.1038/s41586-020-2012-7
  27. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368(6494):1016-1020. https://doi.org/10.1126/science.abb7015
  28. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-292.  https://doi.org/10.1016/j.cell.2020.02.058
  29. Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(21):11727-11734. https://doi.org/10.1073/pnas.2003138117
  30. Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell. 2020;183(4):1043-1057. https://doi.org/10.1016/j.cell.2020.09.033
  31. Laskar P, Yallapu MM, Chauhan SC. “Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies. Diseases. 2020;8(3):30.  https://doi.org/10.3390/diseases8030030
  32. COVID-19 Vaccine & Therapeutics Tracker. 2021. Accessed April 20, 2021. https://biorender.com/covid-vaccine-tracker.
  33. Zhou W, Liu YS, Tian DD, Wang C, Wang S, Cheng J et al. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduction and Targeted Therapy. 2020;5(1):18.  https://doi.org/10.1038/s41392-020-0127-9
  34. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC et al. Remdesivir for the treatment of COVID-19 — Final report. New England Journal of Medicine. 2020;383(19):1813-1826. https://doi.org/10.1056/NEJMoa2007764
  35. Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering. 2020;6(10):1192-1198. https://doi.org/10.1016/j.eng.2020.03.007
  36. Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Research. 2020;179:104811. https://doi.org/10.1016/j.antiviral.2020.104811
  37. Peng X, Wang Y, Xi X, Jia Y, Tian J, Yu B, Tian J. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm. Cardiovascular Drugs and Therapy. 2021;35:231-247.  https://doi.org/10.1007/s10557-020-07120-8
  38. Chilamakuri R, Agarwal S. COVID-19: Characteristics and Therapeutics. Cells. 2021;10(2):206.  https://doi.org/10.3390/cells10020206
  39. Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Frontiers in Cellular and Infection Microbiology. 2020;10:587269. https://doi.org/10.3389/fcimb.2020.587269
  40. Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516-527.  https://doi.org/10.1038/s41586-020-2798-3
  41. Zimmer C, Corum J, Sui-Lee W. Coronavirus Vaccine Tracker. 2021. Accessed April 20, 2021. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html.
  42. Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology. 2020;20(10):615-632.  https://doi.org/10.1038/s41577-020-00434-6
  43. Zaichuk TA, Nechipurenko YD, Adzhubey AA, Onikienko SB, Chereshnev VA, Zainutdinov SS et al. The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector. Molecular Biology. 2020;54(6):812-826.  https://doi.org/10.1134/S0026893320060151
  44. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020;182(4):812-827.  https://doi.org/10.1016/j.cell.2020.06.043
  45. Callaway E. Fast-spreading COVID variant can elude immune responses. Nature. 2021;589(7843):500-501.  https://doi.org/10.1038/d41586-021-00121-z
  46. Abdool Karim SS, de Oliveira T. New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications. New England Journal of Medicine. 2021. https://doi.org/10.1056/NEJMc2100362
  47. Il’icheva TN, Netesov SV, Gureev VN. Influenza viruses. Methods. Novosibirsk: NSU; 2019. (In Russ.).
  48. Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC et al. Influenza. Nature Reviews Disease Primers. 2018;4(1):1-21.  https://doi.org/10.1038/s41572-018-0002-y
  49. Te Velthuis AJW, Fodor E. Influenza virus RNA polymerase: Insights into the mechanisms of viral RNA synthesis. Nature Reviews Microbiology. 2016;14(8):479-493.  https://doi.org/10.1038/nrmicro.2016.87
  50. Carrat F, Flahault A. Influenza vaccine: The challenge of antigenic drift. Vaccine. 2007;25(39-40):6852-6862. https://doi.org/10.1016/j.vaccine.2007.07.027
  51. Hay AJ, Gregory V, Douglas AR, Yi PL. The evolution of human influenza viruses. Philosophical Transactions of the Royal Society B: Biological Sciences. 2001;356(1416):1861-1870. https://doi.org/10.1098/rstb.2001.0999
  52. Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Frontiers in cellular and infection microbiology. 2018;8343. https://doi.org/10.3389/fcimb.2018.00343
  53. Uyeki TM. Preventing and controlling influenza with available interventions. New England Journal of Medicine. 2014;370(9):789-791.  https://doi.org/10.1056/NEJMp1400034
  54. Gubareva L, Mohan T. Antivirals Targeting the Neuraminidase. Cold Spring Harbor Perspectives in Medicine. 2020. https://doi.org/10.1101/cshperspect.a038455
  55. Mishin VP, Patel MC, Chesnokov A, De La Cruz J, Nguyen HT, Lollis L et al. Susceptibility of influenza A, B, C, and D viruses to baloxavir. Emerging Infectious Diseases. 2019;25(10):1969-1972. https://doi.org/10.3201/eid2510.190607
  56. Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research. 2013;100(2):446-454.  https://doi.org/10.1016/j.antiviral.2013.09.015
  57. Ainslie KEC, Haber M, Orenstein WA. Challenges in estimating influenza vaccine effectiveness. Expert Review of Vaccines. 2019;18(6):615-628.  https://doi.org/10.1080/14760584.2019.1622419
  58. Ilyicheva T, Durymanov A, Susloparov I, Kolosova N, Goncharova N, Svyatchenko S et al. Fatal cases of seasonal influenza in Russia in 2015—2016. PLoS One. 2016;11(10):e0165332. https://doi.org/10.1371/journal.pone.0165332
  59. Kolosova NP, Ilyicheva TN, Danilenko AV, Bulanovich JA, Svyatchenko SV, Durymanov AG et al. Severe cases of seasonal influenza in Russia in 2017—2018. PloS One. 2019;14(7):e0220401. https://doi.org/10.1371/journal.pone.0220401
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.